Limited sales of new coronary graft allowed in US
This article was originally published in Clinica
Executive Summary
The FDA has told Possis Medical that it can sell its Perma-Flow coronary bypass graft for use in patients in the US whose own blood vessels cannot be used in coronary bypass surgery.